Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Zhejiang Xianju Pharmaceutical Co Ltd
Other Operating Expenses
Zhejiang Xianju Pharmaceutical Co Ltd
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Z
|
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
|
Other Operating Expenses
¥26.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Other Operating Expenses
-¥64.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Other Operating Expenses
¥27.6m
|
CAGR 3-Years
80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Other Operating Expenses
¥438.9m
|
CAGR 3-Years
24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Other Operating Expenses
-¥60.6m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Other Operating Expenses
¥17.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Zhejiang Xianju Pharmaceutical Co Ltd
Glance View
In the heart of eastern China, Zhejiang Xianju Pharmaceutical Co., Ltd. stands as a testament to China's evolving pharmaceutical prowess. Founded in 1972, Xianju Pharmaceutical has carved out a niche in the global healthcare market by specializing in the production of corticosteroids and hormone APIs (Active Pharmaceutical Ingredients). What sets Xianju apart is its relentless focus on research and development, enabling the company to produce a wide array of steroid and hormone products that cater to both domestic and international markets. The innovation pipeline is fueled by a robust R&D team that ensures the company remains at the forefront of pharmaceutical advancements, allowing it to consistently meet the stringent quality standards expected in this highly regulated industry. The company's financial engine runs on its ability to manufacture these high-demand products efficiently and at scale, leveraging advanced technologies and integrated production processes. This operational efficiency provides Xianju a competitive edge in price stability and market reach. The revenue stream is diversified yet strategically concentrated on its core competencies, allowing Xianju to capitalize on rising global demands for hormone therapies and steroid-related medical treatments. By maintaining strong relationships with global partners and continuously expanding its distribution networks, Zhejiang Xianju Pharmaceutical not only sustains its profitability but also plays a critical role in shaping healthcare outcomes around the world. The company's growth trajectory suggests a finely balanced strategy that combines innovation, production excellence, and market expansion.
See Also
What is Zhejiang Xianju Pharmaceutical Co Ltd's Other Operating Expenses?
Other Operating Expenses
26.9m
CNY
Based on the financial report for Sep 30, 2024, Zhejiang Xianju Pharmaceutical Co Ltd's Other Operating Expenses amounts to 26.9m CNY.
What is Zhejiang Xianju Pharmaceutical Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
17%
You don't have any saved screeners yet